Medicare Enrolled
Dr. Lohaliz Bobe, MD
Pulmonary Disease · Port Charlotte, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bobe from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bobe?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bobe
Dr. Lohaliz Bobe is a pulmonary disease specialist in Port Charlotte, FL, with 16 years of NPI registration. Based on federal Medicare data, Dr. Bobe performed 6,083 Medicare services across 4,341 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bobe received a total of $18,567 from 56 pharmaceutical and/or device companies across 1002 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bobe is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 16 years in practice
▲ Top 4% volume in FL
$18,567 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,083
Medicare services
Top 4% in FL for pulmonary disease
4,341
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~380 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,018 | $95 | $163 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
883 | $95 | $140 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
602 | $172 | $339 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
415 | $33 | $73 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
413 | $42 | $98 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
371 | $37 | $86 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
301 | $60 | $115 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
277 | $64 | $91 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
237 | $20 | $62 |
| Breathing device use evaluation An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling. |
205 | $13 | $30 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
192 | $132 | $217 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
181 | $29 | $107 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
173 | $128 | $221 |
| Overnight continuous oxygen level test This test measures oxygen levels in the blood continuously overnight using a device attached to the ear or finger. |
158 | $19 | $63 |
| Exercise-induced lung stress test A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising. |
139 | $25 | $51 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $131 | $250 |
| New patient office visit, complex (60-74 min) | 79 | $161 | $315 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
68 | $15 | $20 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
67 | $101 | $332 |
| Lung cancer screening counseling visit A visit to discuss the need for lung cancer screening using a low-dose CT scan. This service is used to determine eligibility and facilitate shared decision making. |
56 | $29 | $50 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
43 | $28 | $35 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
22 | $94 | $164 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
20 | $81 | $163 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
18 | $1 | $342 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
15 | $73 | $400 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using a scope and ultrasound to examine the airways and collect tissue samples from three or more lymph nodes. |
14 | $197 | $500 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
12 | $108 | $200 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
12 | $45 | $70 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
12 | $60 | $113 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$18,567
Total received (2018-2024)
Avg $2,652/year across 7 years
Top 12% in FL for pulmonary disease
56
Companies
1,002
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,350 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$217 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,620
2023
$3,596
2022
$3,052
2021
$2,131
2020
$1,492
2019
$2,405
2018
$2,271
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$2,968
AstraZeneca Pharmaceuticals LP
$2,814
Takeda Pharmaceuticals U.S.A., Inc.
$2,310
Actelion Pharmaceuticals US, Inc.
$1,716
Boehringer Ingelheim Pharmaceuticals, Inc.
$931
Regeneron Healthcare Solutions, Inc.
$739
Grifols USA, LLC
$679
Ethicon Inc.
$635
Insmed, Inc.
$628
Mylan Specialty L.P.
$561
GENZYME CORPORATION
$419
Sunovion Pharmaceuticals Inc.
$386
Paratek Pharmaceuticals, Inc.
$324
Bayer HealthCare Pharmaceuticals Inc.
$295
Genentech USA, Inc.
$269
CSL Behring
$232
Novartis Pharmaceuticals Corporation
$225
Bayer Healthcare Pharmaceuticals Inc.
$220
Shire North American Group Inc
$205
United Therapeutics Corporation
$195
Philips Electronics North America Corporation
$169
Amgen Inc.
$155
Circassia Pharmaceuticals Inc
$124
Covidien LP
$120
Electromed, Inc.
$118
Mallinckrodt Hospital Products Inc.
$112
Gilead Sciences, Inc.
$109
ANI Pharmaceuticals, Inc.
$95
Vanda Pharmaceuticals Inc.
$92
Intuitive Surgical, Inc.
$64
Merck Sharp & Dohme LLC
$57
JAZZ PHARMACEUTICALS INC.
$50
Advanced Respiratory, Inc
$44
ABBVIE INC.
$41
Mallinckrodt Enterprises LLC
$33
AbbVie Inc.
$32
Axsome Therapeutics, Inc.
$30
Chiesi USA, Inc.
$28
Ambu Inc.
$26
Kerecis Limited
$26
PORTOLA PHARMACEUTICALS, INC.
$26
BOSTON SCIENTIFIC CORPORATION
$24
Vapotherm Inc
$24
Tactile Systems Technology Inc
$21
PFIZER INC.
$21
Allergan Inc.
$20
La Jolla Pharmaceutical Company
$19
Inogen, Inc.
$19
Janssen Pharmaceuticals, Inc
$18
Boston Scientific Corporation
$18
ADVANCED RESPIRATORY, INC
$18
OptiNose US, Inc.
$15
Veran Medical Technologies, Inc.
$15
Allergan, Inc.
$15
Mallinckrodt LLC
$12
Nabriva Therapeutics, plc
$11
Top 3 companies account for 43.6% of total payments
Associated products mentioned in payments ›
(8874) inCourage · ACTHAR · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVYXXA · BREO · BREZTRI · BREZTRI AEROSPHERE · BROVANA · CLEVIPREX · CUVITRU · DUAKLIR PRESSAIR · DUPIXENT · Da Vinci Surgical System · Dymista · EXPECT · Esbriet · FARXIGA · FASENRA · Flexitouch Plus · GENERAL THROMBECTOMY · GIAPREZA · GLASSIA · HETLIOZ · HYQVIA · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · JARDIANCE · Kcentra · Kerecis Omega3 SurgiClose · LONHALA MAGNAIR · Life 2000 Ventilation System · MONARCH · Monarch Platform · NUCALA · NUZYRA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PREVNAR 20 · PURIFIED CORTROPHIN GEL · Perforomist · Precision Flow · Prolastin-C Liquid · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Spin · Sunosi · SuperDimension · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UTIBRON NEOHALER · Utibron · WINREVAIR · XOLAIR · XYREM · Xenleta · Xhance · Xolair · YUPELRI · Yupelri · Zemaira · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $305 per 100 Medicare services performed
Geographic Context
Pulmonary diseases within 10 mi
9
Per 100K population
4.6
County median income
$66,154
Nearest hospital
Adventhealth Port Charlotte
2.9 mi
2.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Bobe is a clinical cardiology specialist, with above-average Medicare volume (top 4% in FL), with low-engagement industry engagement in the top 12% of FL peers, with 16 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Bobe experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Bobe performed 1,018 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bobe receive payments from pharmaceutical companies?
Yes. Dr. Bobe received a total of $18,567 from 56 companies across 1,002 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bobe's costs compare to other pulmonary diseases in Port Charlotte?
Dr. Bobe's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bobe) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Port Charlotte
Browse pulmonary diseases in Port Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in FL
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in FL
Which FL pulmonary diseases receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology